Top Banner
1 Implementing an Effective CAPA Process Sue Jacobs President QMS Consulting, Inc. Hoffman Estates, IL [email protected] 847.359.4456 Cecilia Kimberlin, PhD Medical Products Group VP Abbott Laboratories Abbott Park, IL [email protected] 847.937.7933
33
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Capa

1

Implementing an Effective CAPA Process

Sue JacobsPresidentQMS Consulting, Inc.Hoffman Estates, [email protected]

Cecilia Kimberlin, PhDMedical Products Group VPAbbott LaboratoriesAbbott Park, [email protected]

Page 2: Capa

2

Topics

Elements of an effective CAPA process Data analysis Getting to probable cause CAPA timeliness Effectiveness checks Learning from experience

Page 3: Capa

3

Elements of an Effective CAPA Process Documented procedure(s) Defined CAPA inputs Risk assessment and

prioritization Investigation disciplines Verification / validation Well defined action plan Disseminate information

Documentation rules Effectiveness checks

Complete? Effective? Timely

Defined criteria for Management Review

Management escalation Metrics - ability to monitor

progress

Page 4: Capa

4

CAPA Simplified

Define the Problem

Initiate CAPA

Investigate Cause

Solution(Action Plan)

Verify / Validate

ConductEffectiveness Check

Implement

Close CAPA

Page 5: Capa

5

EvaluateInitiateCAPA

ComplaintsQuality Records

Servicing

NonconformingProduct

Supply Chain

ProcessMonitoring

Audits Concessions(Deviations)

Threshold met?CAPA already exists?Isolated occurrence?Risk?Collect more data?

Can issue be resolved through: Containment?

Correction? Remediation?

CAPA Inputs

Page 6: Capa

6

CAPA Data Analysis

Analyze Processes, Work Operations Consider what is relevant to your business

Product complexity Process complexity Risk associated with failure

Leverage Design Control to drive CAPA Intended use, essential outputs Manufacturing process design Identification of hazards, estimation of risk Risk control decisions

Page 7: Capa

7

CAPA Data Analysis

Monitor data directly linked to decisions implemented to reduce (control) risk Design FMEA Process FMEA Application FMEA

Hazards and risk mitigation implemented

Page 8: Capa

8

Data Analysis

DesignProduct & Processes

ProductionProcess Controls

Incld. Supply Chain

Post-marketMonitoringComplaints

Define

Monitor

Page 9: Capa

9

CAPA Data Analysis (cont.)

Concessions Use as is, deviations,

temporary changes

Audit Results Recurring audit

observations, internal audits and external audits

Quality Records Evidence of compliance

to your quality system Installation, Distribution,

Change Control,

Post Market data Frequency and

occurrence as expected? Service Records Complaints Returned Products

Page 10: Capa

10

Risk & Prioritization

Establish a prioritization method

Use the method consistently across the quality management system

Complaint Handling Nonconforming Product Supplier Performance Change Control Environmental

Monitoring Process Controls Servicing Audits

Page 11: Capa

11

Investigating Cause

Ultimate goal - determine WHY the problem occurred

Phases of Investigation Presumptive Cause

apparent during early investigation, hypotheses that may explain the effect but needs validation

Contributing Cause secondary and possible causes

Root Cause primary reason for the problem which if corrected will

prevent recurrence

Page 12: Capa

12

A clear problem statement will establish investigation boundaries

The problem statement is the difference between what isis and what should beshould be Focus on

facts – not emotions whatwhat is wrong, not whywhy it’s wrong

Investigating Cause

Page 13: Capa

13

Problem Definition

State the problem in measurable terms how often, how much, when, and where

Emphasize the effects (risk) safety, death, injury, rework, cost, etc.

Avoid negative descriptors, inflammatory statements words that are broad and do not describe the

conditions or behavior such as careless, complacency, neglect, oversight

Page 14: Capa

14

Plan the Investigation

Define method of investigation Include quality tools used

Is/Is Not, Cause and Effect, 5 Why’s, etc.

Document Dates of investigation Data reviewed (data

sources, records, dates) Corrections or Containment

measures Results: Statement of

Cause

Is / Is Not Diagram

WHAT

WHEN

WHERE

EXTENT

IS IS

NOT

EFFECT

PEOPLE MATERIAL

METHODS MEASUREMENT

MACHINE

ENVIRONMENT

Cause

Why

Page 15: Capa

15

Investigating Cause

Implement a solution to address the causecause … … not the not the symptomsymptom

Implementation of a solution that does not address the cause of the problem is costly

Page 16: Capa

16

Effectiveness Checks

Effectiveness Checks Avoid applying the same criteria to all

CAPAs Plan the effectiveness check specific to the

CAPA Identify early detection points to monitor for

recurrence/occurrence

Page 17: Capa

17

Effectiveness Checks

What to do when a effectiveness check fails, and what are the consequences? Close the CAPA and open a new one? Get an extension? Leave the CAPA open and investigate

why?

Page 18: Capa

18

Investigate CauseRe-assess Risk

Proposed Solution

Verify/Validate

Implement

EffectivenessCheck

NO

YES

Data Sourceindicates

problem stillexists.

DetermineAdditional

Action

NO

Action Plan Complete

?

?

Was the Problem

Statement well defined?

Effectiveness Checks

Page 19: Capa

19

Timeliness

Not all CAPAs are created equal

CAPAs age for a reason

Utilize a risk based approach to monitor key steps in the process Initiation Investigation Implementation Closure

Page 20: Capa

20

Timeliness

OpenCAPA

CloseCAPA

Investigation

Verification/ Validation

Solution

Implementation

- Major- Moderate- Minor

- Aging Investigations

- Implementation Overdue

- Failed Effectiveness Checks- Overdue Effectiveness Checks

Effectiveness Check

Page 21: Capa

21

CAPA SystemEffectiveness

Learning from experience

Cecilia Kimberlin, PhDGroup VP QA/RA/MA/Compliance

Abbott Medical Products

Page 22: Capa

22

A focus on execution

The challenges of implementing and sustaining an effective CAPA process Many sources of Quality Data Dissemination of information Connecting the dots Driving global actions Demonstrating Effectiveness AND Efficiency Applying Risk Management principles

Page 23: Capa

23

What should management do?

Evaluate the CAPA system and ability to meet business needs and be in compliance

HOW ?

Page 24: Capa

24

What should we expect over time ? A reduction in quality issues A reduction in the severity of issues More preventive actions over time Better designed products/processes Improved customer satisfaction Better business results

Page 25: Capa

25

What are the symptoms of a less than effective CAPA system?

Recurring issues Inability to “manage” the many sources of

quality data to understand early trends and issues

More reaction than prevention Resources ($$$) are spent on “handling”

failure rather than learning from it and preventing “more of the same”

Field issues

Page 26: Capa

26

What’s so hard about the CAPA Process?

Detect

Analyze

Trend

Investigate

Identify Solutions

Communicate

Verify/Validate

Monitor Effectiveness

Inputs

Outputs

Many Sources of Quality Data

•Internal

•External Implement changes for correction/prevention

Take global actions

Disseminate information

Apply learning

Measure effectiveness

Management review

Apply risk management

RecordsPeople

Page 27: Capa

27

20071997/8

Learning/ Implementation Reactive

Refining/improvin

g Proactive

CAPA

RiskManagement

Human Factors

ManagementResponsibility

Regulatory requirements business requirements

TotalQS

Performance

DesignControls

How well have our systems evolved over the last 10 years?

Page 28: Capa

28

Design Control Products/Processes

Production & ProcessControls

Post-market monitoring

CAPA

CAPA

Now

Process monitoring

PREVENTIVE ACTIONS

CAPA

The CAPA System Quality Improvement

Corrective Actions

Corrections

MANAGEMENT CONTROLS

Ris

k M

anag

emen

t

Page 29: Capa

29

Business with low complexity

Functions

Sites

Medical Device Company

Fewer products, similar in type, fewer people, limited locations, etc.

Analysis & ACTION

•Products

•Parts

•Processes

•Performance

•Systems

Connect the dots ……………….

Page 30: Capa

30

ExternalData

InternalData

DesignControl, etc.

•Oversight•Management Review•Analysis•Take action•Assure effectiveness

Inputs Into CAPA System

Evaluation

Correction Investigation

Cause

Corrective & Preventive Action

Effectiveness Check Tra

ckin

g A

nd T

rend

ing

Page 31: Capa

31

More Complexity?

R&D OPS QAFunctions

Sites

DIV DIV DIV DIV DIV DIV

Headquarters

Now connect the dots ……………….

Page 32: Capa

32

Some points to consider

The right people: training,qualifications, recognition, accountability, communication

IT system – can really help but is not the only answer

Basic good quality and business practices – PDCA, DMAIC, ROI, etc.

Has to work as a closed loop system Scale the system to fit the business Keep it simple and straightforward ! Continuous improvement is the goal

Page 33: Capa

33

Thank-You !Questions? Thoughts? Ideas?

Sue JacobsQMS Consulting, Inc. 847 359 [email protected]

Cecilia KimberlinAbbott Laboratories 847 937 [email protected]